5.78
price down icon1.20%   -0.07
after-market After Hours: 6.40 0.62 +10.73%
loading
Valneva Se Adr stock is traded at $5.78, with a volume of 15,278. It is down -1.20% in the last 24 hours and down -0.54% over the past month. Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
See More
Previous Close:
$5.85
Open:
$5.758838
24h Volume:
15,278
Relative Volume:
0.95
Market Cap:
$462.13M
Revenue:
$163.13M
Net Income/Loss:
$-34.75M
P/E Ratio:
43.01
EPS:
0.1344
Net Cash Flow:
$-231.66M
1W Performance:
-3.51%
1M Performance:
-0.54%
6M Performance:
-25.03%
1Y Performance:
-53.72%
1-Day Range:
Value
$5.70
$5.8559
1-Week Range:
Value
$5.65
$6.06
52-Week Range:
Value
$5.40
$14.49

Valneva Se Adr Stock (VALN) Company Profile

Name
Name
Valneva Se Adr
Name
Phone
-
Name
Address
-
Name
Employee
676
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
VALN's Discussions on Twitter

Valneva Se Adr Stock (VALN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-03-22 Initiated H.C. Wainwright Buy

Valneva Se Adr Stock (VALN) Latest News

pulisher
Oct 12, 2024

H.C. Wainwright maintains Buy rating on Valneva SE stock, lowers price target By Investing.com - Investing.com South Africa

Oct 12, 2024
pulisher
Oct 11, 2024

H.C. Wainwright maintains Buy rating on Valneva SE stock, lowers price target - Investing.com

Oct 11, 2024
pulisher
Oct 04, 2024

Valneva SE Declaration of shares and voting rights - GlobeNewswire Inc.

Oct 04, 2024
pulisher
Sep 25, 2024

H.C. Wainwright updates Valneva SE outlook following capital raise, reiterates Buy - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

H.C. Wainwright updates Valneva SE outlook following capital raise, reiterates Buy By Investing.com - Investing.com South Africa

Sep 25, 2024
pulisher
Sep 25, 2024

In-Depth Examination Of 6 Analyst Recommendations For Valneva - Benzinga

Sep 25, 2024
pulisher
Sep 13, 2024

Valneva Announces the Success of its Private Placement Raising approximately €60 Million - GlobeNewswire Inc.

Sep 13, 2024
pulisher
Sep 04, 2024

Valneva shares hold strong with buy rating on Lyme vaccine data - Investing.com

Sep 04, 2024
pulisher
Sep 04, 2024

Wall Street Analysts Predict a 150.41% Upside in Valneva (VALN): Here's What You Should Know - MSN

Sep 04, 2024
pulisher
Sep 03, 2024

Favorable VLA15 Phase 2 Study Results Might Boost VALN Stock - Zacks Investment Research

Sep 03, 2024
pulisher
Aug 15, 2024

How Much Upside is Left in Valneva (VALN)? Wall Street Analysts Think 135.3% - Yahoo Finance

Aug 15, 2024
pulisher
Jul 26, 2024

Can Valneva (VALN) Climb 149.04% to Reach the Level Wall Street Analysts Expect? - Zacks Investment Research

Jul 26, 2024
pulisher
Jul 22, 2024

What Analysts Are Saying About Valneva Stock - Benzinga

Jul 22, 2024
pulisher
Jul 08, 2024

Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine - Zacks Investment Research

Jul 08, 2024
pulisher
Jun 26, 2024

Wall Street Analysts See a 65% Upside in Valneva SE Sponsored ADR (VALN): Can the Stock Really Move This High? - Yahoo New Zealand News

Jun 26, 2024
pulisher
Jun 24, 2024

Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval - Yahoo Finance

Jun 24, 2024
pulisher
Jun 10, 2024

Valneva (VALN) Stock Down 53% in the Past Year: Here's Why - Yahoo Sport Australia

Jun 10, 2024
pulisher
May 30, 2024

Valneva SE Sponsored ADR (VALN) Stock Jumps 93.1%: Will It Continue to Soar? - Yahoo New Zealand News

May 30, 2024
pulisher
May 26, 2024

Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why - Yahoo Lifestyle UK

May 26, 2024
pulisher
Mar 21, 2024

Earnings call: Valneva reports robust growth and strategic R&D focus By Investing.com - Investing.com South Africa

Mar 21, 2024
pulisher
Feb 20, 2024

France stocks mixed at close of trade; CAC 40 up 0.34% By Investing.com - Investing.com

Feb 20, 2024
pulisher
Jan 24, 2024

France stocks mixed at close of trade; CAC 40 up 0.91% - Investing.com

Jan 24, 2024
pulisher
Jan 03, 2023

What Makes Valneva SE Sponsored ADR (VALN) a New Buy Stock - Yahoo Finance

Jan 03, 2023
pulisher
Dec 06, 2022

Valneva (VALN) Up on Antibody Persistence Data on Chikungunya Jab - Yahoo Lifestyle Singapore

Dec 06, 2022
pulisher
Jun 14, 2022

Valneva (VALN) Down on its COVID-19 Vaccine Update in Europe - Zacks Investment Research

Jun 14, 2022
pulisher
Apr 03, 2022

5 Top Health Care Stocks To Watch In The Stock Market Today - Stock Market

Apr 03, 2022
pulisher
Nov 24, 2021

Valneva Stock Is Jumping on European Vaccine Supply Deal - Barron's

Nov 24, 2021
pulisher
Nov 10, 2021

Valneva Stock Surges After EU Vaccine Deal - Investing.com

Nov 10, 2021
pulisher
Oct 27, 2021

Valneva Shares Off 12% On Share Offering News By Investing.com - Investing.com UK

Oct 27, 2021
pulisher
May 07, 2021

EU set to sign off new Pfizer vaccine contract as soon as Friday - Luxembourg Times

May 07, 2021
pulisher
Feb 18, 2021

Valneva Races Ahead in Stock Market Even as Vaccine Lags Behind - Bloomberg

Feb 18, 2021
pulisher
Jul 08, 2019

Shareholder Structure - Valneva

Jul 08, 2019
pulisher
Jul 08, 2019

Stock Price - Valneva

Jul 08, 2019

Valneva Se Adr Stock (VALN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):